Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBRIEF COMMUNICATION

Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma

Christina Laschinsky, Sarah Theurer, Thomas Herold, Josefine Rawitzer, Frank Weber, Ken Herrmann, Tim Brandenburg, Dagmar Führer-Sakel, Wolfgang P. Fendler and Manuel Weber
Journal of Nuclear Medicine December 2023, 64 (12) 1865-1868; DOI: https://doi.org/10.2967/jnumed.123.266044
Christina Laschinsky
1Department of Nuclear Medicine, University Hospital Essen, Essen, Germany;
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Theurer
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
3Institute of Pathology, University Hospital Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Herold
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
3Institute of Pathology, University Hospital Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josefine Rawitzer
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
3Institute of Pathology, University Hospital Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank Weber
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
4Department of Surgery, Section of Endocrine Surgery, Essen University Hospital, Essen, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
1Department of Nuclear Medicine, University Hospital Essen, Essen, Germany;
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tim Brandenburg
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
5Department of Endocrinology, Diabetes, and Metabolism, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dagmar Führer-Sakel
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
5Department of Endocrinology, Diabetes, and Metabolism, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang P. Fendler
1Department of Nuclear Medicine, University Hospital Essen, Essen, Germany;
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Weber
1Department of Nuclear Medicine, University Hospital Essen, Essen, Germany;
2German Cancer Consortium, Partner Site Essen, Essen, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 64 no. 12 1865-1868
DOI 
https://doi.org/10.2967/jnumed.123.266044
PubMed 
37884333

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 22, 2023
  • Revision received September 27, 2023
  • Published online December 1, 2023.

Article Versions

  • previous version (October 26, 2023 - 08:39).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Christina Laschinsky1,2,
  2. Sarah Theurer2,3,
  3. Thomas Herold2,3,
  4. Josefine Rawitzer2,3,
  5. Frank Weber2,4,
  6. Ken Herrmann1,2,
  7. Tim Brandenburg2,5,
  8. Dagmar Führer-Sakel2,5,
  9. Wolfgang P. Fendler1,2 and
  10. Manuel Weber1,2
  1. 1Department of Nuclear Medicine, University Hospital Essen, Essen, Germany;
  2. 2German Cancer Consortium, Partner Site Essen, Essen, Germany;
  3. 3Institute of Pathology, University Hospital Essen, Essen, Germany;
  4. 4Department of Surgery, Section of Endocrine Surgery, Essen University Hospital, Essen, Germany; and
  5. 5Department of Endocrinology, Diabetes, and Metabolism, University Hospital Essen, University of Duisburg–Essen, Essen, Germany
  1. For correspondence or reprints, contact Christina Laschinsky (christina.laschinsky{at}uk-essen.de).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Advances in Radioligand Theranostics in Oncology
    Ismaheel O. Lawal, Sofiullah O. Abubakar, Honest Ndlovu, Kgomotso M. G. Mokoala, Stuart S. More, Mike M. Sathekge
    Molecular Diagnosis & Therapy 2024 28 3
  • Colorimetric and Photothermal Dual-modal Visual Detection of Iodide Ion Based on G-Quadruplex-Hemin Cascade Signal Amplification
    Yanyue Chen, Jiali Liu, Jiawen Liu, Rong Hu, Yunhui Yang, Xiaobing Zhang
    Chemical Research in Chinese Universities 2024 40 2
  • Key data from the 2024 European Thyroid Association annual congress: What's new in aggressive thyroid carcinoma?
    Louis Schubert, Magalie Haissaguerre, Philippe Caron, Lionel Groussin
    Annales d'Endocrinologie 2025 86 4

Article usage

Article usage: October 2023 to May 2025

AbstractFullPdf
Oct 202359117867
Nov 202346123088
Dec 2023664302159
Jan 202427424068
Feb 202410021723
Mar 20248317433
Apr 20245819739
May 20241693214
Jun 20245310832
Jul 20243226843
Aug 20243119636
Sep 2024224429
Oct 2024214639
Nov 2024374949
Dec 2024225137
Jan 2025312321
Feb 2025167019
Mar 2025255125
Apr 2025244241
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (12)
Journal of Nuclear Medicine
Vol. 64, Issue 12
December 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma
Christina Laschinsky, Sarah Theurer, Thomas Herold, Josefine Rawitzer, Frank Weber, Ken Herrmann, Tim Brandenburg, Dagmar Führer-Sakel, Wolfgang P. Fendler, Manuel Weber
Journal of Nuclear Medicine Dec 2023, 64 (12) 1865-1868; DOI: 10.2967/jnumed.123.266044

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma
Christina Laschinsky, Sarah Theurer, Thomas Herold, Josefine Rawitzer, Frank Weber, Ken Herrmann, Tim Brandenburg, Dagmar Führer-Sakel, Wolfgang P. Fendler, Manuel Weber
Journal of Nuclear Medicine Dec 2023, 64 (12) 1865-1868; DOI: 10.2967/jnumed.123.266044
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Bioanalytic Hybrid System Merging 3-Dimensional Cell Culture and Chromatographic Precision for Unprecedented Preclinical Insights in Molecular Imaging
  • Radiances of Cerenkov-Emitting Radionuclides on the In Vivo Imaging System
  • Measuring Total Metabolic Tumor Volume from 18F-FDG PET: A Reality Check
Show more BRIEF COMMUNICATION

Similar Articles

Keywords

  • molecular imaging
  • radionuclide therapy
  • molecular alterations
  • papillary thyroid cancer
  • radioiodine refractoriness
  • TP53
SNMMI

© 2025 SNMMI

Powered by HighWire